Cargando…

Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006–2016

BACKGROUND: Germline pathogenic variants in BRCA1/2 have been established in hereditary breast and ovarian cancer (HBOC) syndrome and result in significantly elevated lifetime risk of ovarian cancer. Risk reduction interventions are presently the only effective means of improving survival and specia...

Descripción completa

Detalles Bibliográficos
Autores principales: Adolph, Lauren, Warias, Ashley, Stairs, Jocelyn, Collins-McNeil, Kelly, Penney, Lynette, Kieser, Katharina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245201/
https://www.ncbi.nlm.nih.gov/pubmed/35768821
http://dx.doi.org/10.1186/s12905-022-01844-5
_version_ 1784738696162967552
author Adolph, Lauren
Warias, Ashley
Stairs, Jocelyn
Collins-McNeil, Kelly
Penney, Lynette
Kieser, Katharina
author_facet Adolph, Lauren
Warias, Ashley
Stairs, Jocelyn
Collins-McNeil, Kelly
Penney, Lynette
Kieser, Katharina
author_sort Adolph, Lauren
collection PubMed
description BACKGROUND: Germline pathogenic variants in BRCA1/2 have been established in hereditary breast and ovarian cancer (HBOC) syndrome and result in significantly elevated lifetime risk of ovarian cancer. Risk reduction interventions are presently the only effective means of improving survival and specialized counselling clinics have been established as an effective means of aiding this population in navigating complex decisions surrounding these interventions. This study sought to evaluate patient perceptions of a specialized counselling clinic for patients with HBOC Syndrome and referral patterns to this clinic. METHODS: We completed a retrospective review of 200 patients with HBOC in Nova Scotia, Canada seen through Maritime Medical Genetics Services between 2006 and 2016. Data were collected on referral pattern to the Hereditary Gynaecologic Risk Reduction Clinic (HGRRC), demographics, health history, and uptake of risk-reducing interventions. Participants were invited to complete a questionnaire about their experience. RESULTS: 156/200(78%) women were referred to HGRCC and 135/156 (85.9%) of those referred attended their appointment. 124/200 (62%) were over age 40 at the time of testing. The mean time from referral to HGRCC appointment was 134.68 days (SD 85.78). 85/135 (63%) underwent risk-reducing bilateral salpingo-oophorectomy following their HGRCC appointment. The questionnaire was completed by 94/188 (50.3%) women. Most participants found information received from genetics clinics (81/94; 91%) and genetic counsellors (87/94; 95%) most helpful in making choices around risk-reduction strategies. 83/94 (88%) participants felt they had sufficient information to make an informed decision. CONCLUSION: The majority of women with HBOC in Nova Scotia during the study period were referred to and counselled through HGRRC. Genetic counselling was found most valuable in risk-reduction decision making, which highlights the importance of a multidisciplinary team. Patients viewed this clinic as an effective care model to support informed choice about risk-reducing intervention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-022-01844-5.
format Online
Article
Text
id pubmed-9245201
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92452012022-07-01 Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006–2016 Adolph, Lauren Warias, Ashley Stairs, Jocelyn Collins-McNeil, Kelly Penney, Lynette Kieser, Katharina BMC Womens Health Research BACKGROUND: Germline pathogenic variants in BRCA1/2 have been established in hereditary breast and ovarian cancer (HBOC) syndrome and result in significantly elevated lifetime risk of ovarian cancer. Risk reduction interventions are presently the only effective means of improving survival and specialized counselling clinics have been established as an effective means of aiding this population in navigating complex decisions surrounding these interventions. This study sought to evaluate patient perceptions of a specialized counselling clinic for patients with HBOC Syndrome and referral patterns to this clinic. METHODS: We completed a retrospective review of 200 patients with HBOC in Nova Scotia, Canada seen through Maritime Medical Genetics Services between 2006 and 2016. Data were collected on referral pattern to the Hereditary Gynaecologic Risk Reduction Clinic (HGRRC), demographics, health history, and uptake of risk-reducing interventions. Participants were invited to complete a questionnaire about their experience. RESULTS: 156/200(78%) women were referred to HGRCC and 135/156 (85.9%) of those referred attended their appointment. 124/200 (62%) were over age 40 at the time of testing. The mean time from referral to HGRCC appointment was 134.68 days (SD 85.78). 85/135 (63%) underwent risk-reducing bilateral salpingo-oophorectomy following their HGRCC appointment. The questionnaire was completed by 94/188 (50.3%) women. Most participants found information received from genetics clinics (81/94; 91%) and genetic counsellors (87/94; 95%) most helpful in making choices around risk-reduction strategies. 83/94 (88%) participants felt they had sufficient information to make an informed decision. CONCLUSION: The majority of women with HBOC in Nova Scotia during the study period were referred to and counselled through HGRRC. Genetic counselling was found most valuable in risk-reduction decision making, which highlights the importance of a multidisciplinary team. Patients viewed this clinic as an effective care model to support informed choice about risk-reducing intervention. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12905-022-01844-5. BioMed Central 2022-06-29 /pmc/articles/PMC9245201/ /pubmed/35768821 http://dx.doi.org/10.1186/s12905-022-01844-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Adolph, Lauren
Warias, Ashley
Stairs, Jocelyn
Collins-McNeil, Kelly
Penney, Lynette
Kieser, Katharina
Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006–2016
title Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006–2016
title_full Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006–2016
title_fullStr Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006–2016
title_full_unstemmed Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006–2016
title_short Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006–2016
title_sort hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006–2016
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245201/
https://www.ncbi.nlm.nih.gov/pubmed/35768821
http://dx.doi.org/10.1186/s12905-022-01844-5
work_keys_str_mv AT adolphlauren hereditaryovariancancerriskreductionaretrospectiveevaluationofpatientperspectivesandserviceprovisionataregionalhereditarygynaecologiccancerclinic20062016
AT wariasashley hereditaryovariancancerriskreductionaretrospectiveevaluationofpatientperspectivesandserviceprovisionataregionalhereditarygynaecologiccancerclinic20062016
AT stairsjocelyn hereditaryovariancancerriskreductionaretrospectiveevaluationofpatientperspectivesandserviceprovisionataregionalhereditarygynaecologiccancerclinic20062016
AT collinsmcneilkelly hereditaryovariancancerriskreductionaretrospectiveevaluationofpatientperspectivesandserviceprovisionataregionalhereditarygynaecologiccancerclinic20062016
AT penneylynette hereditaryovariancancerriskreductionaretrospectiveevaluationofpatientperspectivesandserviceprovisionataregionalhereditarygynaecologiccancerclinic20062016
AT kieserkatharina hereditaryovariancancerriskreductionaretrospectiveevaluationofpatientperspectivesandserviceprovisionataregionalhereditarygynaecologiccancerclinic20062016